Gurbel, P. A., Bliden, K. P., Turner, S. E., Tantry, U. S., Gesheff, M. G., Barr, T. P., . . . Kuliopulos, A. (2016). Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, 36(1), 189. https://doi.org/10.1161/ATVBAHA.115.306777
Citace podle Chicago (17th ed.)Gurbel, Paul A., Kevin P. Bliden, Susan E. Turner, Udaya S. Tantry, Martin G. Gesheff, Travis P. Barr, Lidija Covic, a Athan Kuliopulos. "Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease." Arteriosclerosis, Thrombosis, and Vascular Biology 36, no. 1 (2016): 189. https://doi.org/10.1161/ATVBAHA.115.306777.
Citace podle MLA (9th ed.)Gurbel, Paul A., et al. "Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 1, 2016, p. 189, https://doi.org/10.1161/ATVBAHA.115.306777.